by
Brendon Nafziger, DOTmed News Associate Editor | November 01, 2010
McKesson Corp., a health IT powerhouse and the nation's biggest drug distributor, said Monday it would buy closely held oncology-services company U.S. Oncology for a cash deal valued at $2.16 billion.
The deal, with a targeted closing date of Dec. 31, includes the assumption of Woodlands, Texas-based U.S. Oncology's outstanding debt.
By scooping up U.S. Oncology from its owners, New York private equity firm Welsh Carson Anderson & Stowe, McKesson hopes to expand its cancer range. The company currently works with 1,000 oncologists, providing service to 17 percent of all U.S. cancer patients, according to BusinessWeek. The combined company will include 3,000 oncologists, the paper said.
Ad Statistics
Times Displayed: 186622
Times Visited: 4999 For those who need to move fast and expand clinical capabilities -- and would love new equipment -- the uCT 550 Advance offers a new fully configured 80-slice CT in up to 2 weeks with routine maintenance and parts and Software Upgrades for Life™ included.
San Francisco-based McKesson rose 2.36 percent in morning trading to reach $67.54 per share, a three-month high.
